Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

EVG

Evgen Pharma (EVG)

Evgen Pharma Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:EVG
DateHeureSourceTitreSymboleSociété
25/04/202421h57Alliance NewsAlliance NewsTRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading wellLSE:EVGEvgen Pharma Plc
25/04/202416h46RNS Regulatory NewsEvgen Pharma PLC Change of NameLSE:EVGEvgen Pharma Plc
22/04/202411h11RNS Regulatory NewsEvgen Pharma PLC Holding(s) in CompanyLSE:EVGEvgen Pharma Plc
05/04/202416h39RNS Regulatory NewsEvgen Pharma PLC Director/PDMR ShareholdingLSE:EVGEvgen Pharma Plc
04/04/202418h24Alliance NewsAlliance NewsTRADING UPDATES: Northcoders launches bootcamp; Schroder investsLSE:EVGEvgen Pharma Plc
04/04/202414h59RNS Regulatory NewsEvgen Pharma PLC Result of General MeetingLSE:EVGEvgen Pharma Plc
04/04/202408h00RNS Regulatory NewsEvgen Pharma PLC Result of Retail OfferLSE:EVGEvgen Pharma Plc
19/03/202420h47Alliance NewsAlliance NewsEARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flatLSE:EVGEvgen Pharma Plc
19/03/202418h03RNS Regulatory NewsEvgen Pharma PLC Retail OfferLSE:EVGEvgen Pharma Plc
19/03/202418h00RNS Regulatory NewsEvgen Pharma PLC Acquisition, Fundraising and Change of NameLSE:EVGEvgen Pharma Plc
27/02/202416h59Alliance NewsAlliance NewsEvgen Pharma finds evidence of SFX-01 activity in colon cancer modelsLSE:EVGEvgen Pharma Plc
27/02/202408h00RNS Non-RegulatoryEvgen Pharma PLC SFX-01 positive update in bowel cancer modelsLSE:EVGEvgen Pharma Plc
19/02/202412h45Alliance NewsAlliance NewsEvgen Pharma shares up on studies into SFX-01 product progressing wellLSE:EVGEvgen Pharma Plc
19/02/202412h22RNS Non-RegulatoryEvgen Pharma PLC Positive update on SFX-01 in vitro GBM studiesLSE:EVGEvgen Pharma Plc
09/02/202419h53Alliance NewsAlliance NewsTRADING UPDATES: Apax opts against lifting offer; DCI enters loan dealLSE:EVGEvgen Pharma Plc
09/02/202412h01RNS Regulatory NewsEvgen Pharma PLC Notice of Dispute lodged with Stalicla SALSE:EVGEvgen Pharma Plc
16/01/202419h59Alliance NewsAlliance NewsIN BRIEF: Evgen partner raises USD17.4 million to support pipelineLSE:EVGEvgen Pharma Plc
16/01/202416h07RNS Non-RegulatoryEvgen Pharma PLC Series B Fund Raise by partner, Stalicla SALSE:EVGEvgen Pharma Plc
22/12/202319h06Alliance NewsAlliance NewsIN BRIEF: Evgen appoints Toni Hanninen as permanent CFOLSE:EVGEvgen Pharma Plc
22/12/202308h00UK RegulatoryEvgen Pharma PLC Directorate ChangesLSE:EVGEvgen Pharma Plc
13/11/202308h00RNS Non-RegulatoryEvgen Pharma PLC Upcoming conferencesLSE:EVGEvgen Pharma Plc
31/10/202315h38Alliance NewsAlliance NewsTRADING UPDATES: Acuity RM wins contract; Georgia Capital ups earningsLSE:EVGEvgen Pharma Plc
31/10/202308h00UK RegulatoryEvgen Pharma PLC Half-year ReportLSE:EVGEvgen Pharma Plc
26/10/202308h00RNS Non-RegulatoryEvgen Pharma PLC Erasmus Medical Center begins glioblastoma studiesLSE:EVGEvgen Pharma Plc
19/10/202320h39Alliance NewsAlliance NewsIN BRIEF: Evgen showcases importance of new enteric-coated formulationLSE:EVGEvgen Pharma Plc
19/10/202315h26RNS Non-RegulatoryEvgen Pharma PLC Authored Article PublicationLSE:EVGEvgen Pharma Plc
05/09/202315h22Alliance NewsAlliance NewsEvgen Pharma hires interim CFO from Faron, chair to retire this monthLSE:EVGEvgen Pharma Plc
15/08/202311h01Alliance NewsAlliance NewsEvgen Pharma says trial shows new SFX-01 drug formulation is safeLSE:EVGEvgen Pharma Plc
15/08/202308h00UK RegulatoryEvgen Pharma PLC Final Report from Phase 1b PK/PD studyLSE:EVGEvgen Pharma Plc
03/08/202313h38UK RegulatoryEvgen Pharma PLC Rule 17 DisclosureLSE:EVGEvgen Pharma Plc
 Showing the most relevant articles for your search:LSE:EVG

Dernières Valeurs Consultées

Delayed Upgrade Clock